MedPath

An observational trial to study the effect of fluid accumulation on acute confusional state in patients admitted to the intensive care unit(ICU) with severe infection using CAM-ICU score and a non-ivasive monitor called functional near-infrared spectroscopy (fNIRS) for forebrain mapping.

Not Applicable
Conditions
Health Condition 1: B968- Other specified bacterial agents as the cause of diseases classified elsewhere
Registration Number
CTRI/2024/02/062440
Lead Sponsor
AIIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Admitted to the ICU within 24 hours of having been diagnosed with septic shock.

Defined by Sepsis-3 consensus guidelines as a suspected or confirmed source of infection with Sequential organ failure assessment (SOFA) more than or equal to 2 and shock.

Shock is defined as hypotension requiring persistent vasopressor therapy to maintain mean arterial pressure (MAP) of more than 65 mmHg and serum lactate levels greater than 2 mmol per L despite adequate initial fluid resuscitation (at least 30ml per kg of IBW).

Exclusion Criteria

Patients on short term mechanical ventilation less than 48 hours.

A pre-ICU diagnosis of cognitive dysfunction as indicated by their medical records on admission, or a primary central nervous system diagnosis like cerebrovascular accident, meningitis, seizure disorder, psychiatric disorder, hypoxic encephalopathy post cardiac arrest.

Death before assessment of ICU-delirium within 3 days of ICU admission.

Life-threatening bleeding, the presence of hemorrhagic shock, as judged by research or treating clinicians.

Burns, Pregnancy.

Referral from or treated at other healthcare facilities.

Patients with a likely extracerebral source of serum S100B elevation (e.g., severe disabling neuromuscular disorders, severe burns, advanced malignancy, polytrauma, and chronic renal failure).

Readmission to ICU.

Withdrawal of consent.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath